Stewart Hillis

Stewart Hillis's AcademicInfluence.com Rankings

Stewart Hillis

Philosophy

#11718

World Rank

#16187

Historical Rank

Logic

#8522

World Rank

#10680

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Stewart Hillis Influential?

(Suggest an Edit or Addition)

According to Wikipedia, William Stewart Hillis was a Scottish physician who held a professorship in cardiology and exercise medicine. He was doctor for the Scotland national football team for 228 full international matches, part of his involvement with football that spanned more than 40 year during his medical career. He was vice-chairman of the UEFA medical committee and medical advisor to FIFA.

(See a Problem?)

Stewart Hillis's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial (2002) (616)
Migraine Intervention With STARFlex Technology (MIST) Trial: A Prospective, Multicenter, Double-Blind, Sham-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With STARFlex Septal Repair Implant to Resolve Refractory Migraine Headache (2008) (556)
CORONARY ANGIOPLASTY VERSUS CORONARY-ARTERY BYPASS-SURGERY - THE RANDOMIZED INTERVENTION TREATMENT OF ANGINA (RITA) TRIAL (1993) (335)
Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO) (1997) (229)
Effect of Subcutaneous Sumatriptan, a Selective 5HT1 Agonist, on the Systemic, Pulmonary, and Coronary Circulation (1993) (200)
Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. (1998) (182)
BioSTAR Evaluation STudy (BEST): A Prospective, Multicenter, Phase I Clinical Trial to Evaluate the Feasibility, Efficacy, and Safety of the BioSTAR Bioabsorbable Septal Repair Implant for the Closure of Atrial-Level Shunts (2006) (137)
Exercise prescription in adults with congenital heart disease: a long way to go (2000) (123)
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate. (1987) (117)
Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. (1988) (115)
The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation. (1992) (109)
Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. (1985) (86)
A prospective randomized trial of tocainide in patients following myocardial infarction. (1980) (85)
Familial pattern of corticosteroids and their metabolism in adult human subjects--the Scottish Adult Twin Study. (1999) (81)
The genetic determination of left ventricular mass in healthy adults. (2003) (80)
Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction (1990) (66)
A species difference in the presystemic metabolism of carbazeran in dog and man. (1984) (59)
Leucocyte ascorbic acid levels after acute myocardial infarction. (1972) (59)
Haemodynamic effects of prenalterol in patients with coronary heart disease. (1980) (56)
Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease. (1997) (51)
Walk or run? is high-intensity exercise more effective than moderate-intensity exercise at reducing cardiovascular risk? (2012) (49)
The ergoreflex in patients with chronic stable heart failure. (1999) (49)
The determination of carotid intima medial thickness in adults--a population-based twin study. (2003) (46)
SYSTOLIC TIME INTERVALS IN THYROID DISEASE (1975) (44)
Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction. (1999) (42)
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG (1992) (40)
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. (1989) (39)
Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D‐receptor agonist (1999) (38)
Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. (1975) (38)
An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects (2001) (38)
Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase. (1994) (37)
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. (1997) (36)
A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction. (1991) (36)
Reduced heart rate variability following repair of tetralogy of Fallot (1999) (35)
Reactive hyperemia: an index of the significance of coronary stenoses. (1976) (35)
Outcomes of transposition of the great arteries in the era of atrial inflow correction (1998) (35)
The effects of acute dynamic exercise on haemostasis in first class Scottish football referees (2008) (32)
The long-term management of the patient with an aortic coarctation repair. (1998) (30)
Management of polycythaemia in adults with cyanotic congenital heart disease (1999) (27)
Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects. (1985) (27)
The pharmacokinetics of R- and S-tocainide in patients with acute ventricular arrhythmias. (1986) (26)
Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain (2005) (26)
The continuing debate: conservative or interventional therapy for unstable coronary artery disease. (1997) (26)
The prevalence of left ventricular hypertrophy in elite professional footballers. (1999) (25)
Impact of nicorandil in angina: subgroup analyses (2004) (25)
Haemodynamics and myocardial function after sotalol. (1972) (25)
A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteers. (1991) (25)
Failure of single dose amoxycillin as prophylaxis against endocarditis (1984) (24)
Athletic left ventricular hypertrophy: long-term studies are required. (2000) (23)
Hospital volume of throughput and periprocedural and medium-term adverse events after percutaneous coronary intervention: retrospective cohort study of all 17 417 procedures undertaken in Scotland, 1997–2003 (2006) (21)
Questionnaire survey of thrombolytic treatment in accident and emergency departments in the United Kingdom (1998) (19)
The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction. (1985) (19)
Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study. (2005) (19)
ABC of Sports Medicine: Sudden death in sport (1994) (19)
Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. (1988) (17)
Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. (1988) (16)
Effects of subcutaneous naratriptan on systemic and pulmonary haemodynamics and coronary artery diameter in humans. (1999) (15)
Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. (1994) (15)
Electrocardiographic evidence of myocardial salvage after thrombolysis in acute myocardial infarction. (1989) (15)
The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance. (1993) (15)
Pharmacodynamics of amlodipine: hemodynamic effects and antianginal efficacy after atrial pacing. (1989) (15)
Endocarditis in intravenous drug abusers with staphylococcal septicaemia. (1989) (15)
The acute haemodynamic effects of intravenous enalaprilic acid (MK422) in patients with left ventricular dysfunction. (1987) (14)
Sumatriptan-induced chest pain (1994) (14)
Areas of emerging interest in analgesia: cardiovascular complications. (2002) (14)
Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction. (1976) (12)
Responses to constant work exercise in patients with chronic heart failure (1999) (12)
Family planning requirements of adults with congenital heart disease. (1997) (11)
CABG in the elderly: the Glasgow experience. (1989) (11)
Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease. (1977) (11)
Epileptiform seizures and electroencephalographic abnormalities as manifestations of digoxin toxicity. (1982) (10)
Intracoronary Thrombolytic Therapy Performed within a Coronary Care Unit: One Year's Experience (1986) (10)
Changes in Lignocaine Disposition during Long‐Term Infusion in Patients with Acute Ventricular Arrhythmias (1987) (10)
Effect of exercise in hypertension controlled with metoprolol or methyldopa. (1979) (10)
THE EFFECTS OF A NEW β‐ADRENOCEPTOR BLOCKING COMPOUND, TOLAMOLOL, ON HAEMODYNAMICS AND MYOCARDIAL FUNCTION IN MAN (1974) (9)
Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring. (1983) (9)
The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans? (1999) (9)
Phosphodiesterase inhibitors: haemodynamic effects related to the treatment of cardiac failure. (1982) (9)
Effect of afterload reduction in patients with ventricular and physiological pacing. (1984) (8)
The haematological management of patients with cyanotic congenital heart disease. A time for consensus? (1997) (8)
Cardiac standstill due to digoxin poisoning successfully treated with atrial pacing. (1973) (8)
Screening for hypertrophic cardiomyopathy. (1993) (8)
Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. (1993) (8)
Non-invasive cardiovascular assessment of indapamide in patients with essential hypertension. (1981) (7)
Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action. (1987) (7)
Surgery in asymptomatic aortic stenosis (2004) (7)
Ventilatory response to erect and supine exercise. (1999) (7)
Effects of exercise position on the ventilatory responses to exercise in chronic heart failure. (1998) (6)
Haemodynamic effects of BM 10.188, a new orally active inotropic agent, in healthy volunteers. (1982) (6)
Long‐term comparison of metoprolol and methyldopa in the treatment of hypertension (1980) (5)
Chronic Valvular Disease of the Heart (1985) (5)
Effect of ketanserin on central haemodynamics and coronary circulation. (1998) (5)
GEMS–RCPSG: ‘Is Academic Medicine for Me?’ National Conference 2011, 19 November 2011 (2012) (5)
Glucocorticoids contribute to the heritability of leptin in Scottish adult female twins (2004) (5)
Left ventricular aneurysm complicating acute myocardial infarction occurring during pregnancy (1983) (5)
THE EFFECTS OF PROPRANOLOL AND ACEBUTOLOL ON LEFT VENTRICULAR FUNCTION AND CORONARY HAEMODYNAMICS IN THE CONSCIOUS DOG WITH MYOCARDIAL ISCHAEMIA (1980) (4)
Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland. (1996) (4)
Reactive hyperemia as an index to coronary arterial narrowing. (1975) (4)
Thrombolytic therapy in acute myocardial infarction in the elderly. (1987) (4)
Antimycobacterial hsp65 and rheumatoid factor titres in a population of normal twins: evidence of genetic control of rheumatoid factor (1995) (4)
after acute myocardial infarction . Leucocyte ascorbic acid levels (4)
Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris. (1980) (4)
Significance of severity of coronary arterial stenosis: metabolic studies and correlation with hyperemic response. (1975) (3)
Electrophysiological Effects of Felodipine (2012) (3)
Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan. (1999) (3)
Electrophysiological Effects of Felodipine in Combination with Metoprolol (2012) (3)
Long-term amiodarone therapy raises serum cholesterol (2004) (3)
Modern management of heart failure. (1986) (3)
Amiodarone therapy and glucose tolerance — A prospective trial (2004) (3)
Failure of single dose amoxycillin as prophylaxis against endocarditis. (1984) (2)
The role of intervention following thrombolysis for acute myocardial infarction. (1990) (2)
CAPTOPRIL/METOLAZONE INDUCED RENAL FAILURE (1986) (2)
Role of the general practitioner in managing patients with myocardial infarction. (1989) (2)
IN PATIENTS WITH CORONARY HEART DISEASE (2006) (2)
Management strategies in unstable coronary artery disease—Current problems and future directions (1999) (1)
ST segment changes as a surrogate end point in coronary thrombolysis. (1990) (1)
Exercise testing, symptoms, and clinical outcome in aortic stenosis (2000) (1)
Achievement of Coronary Artery Patency by Use of Anisoylated Plasminogen Streptokinase Activator Complex in Acute Myocardial Infarction (2012) (1)
The effect of glyceryl trinitrate ointment on heart rate--corrected systolic time intervals in angina pectoris. (1982) (1)
Angiomatous arteriovenous fistula between aorta, great cardiac vein and pulmonary artery. An incidental finding during mitral valvotomy. (1978) (1)
Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man. (1991) (1)
Familial influences on QT and QTc dispersion (1997) (0)
C-Reactive Protein Does not Correlate with Severity of Coronary Atherosclerosis in Patients with Stable Angina (1996) (0)
patencyafter thrombolytic treatmentinacute myocardial infarction: use oftheST segment as a non-invasivemarker (1988) (0)
(MK422) in patients with left ventricular dysfunction (2006) (0)
The Effect of Ketanserin on Central Haemodynamics and Coronary Circulation (1996) (0)
Does Helicobacter Pylori Infection Lead to Increased Cardiovascular Risk by An Auto-Immune Process? (1996) (0)
Thrombolytic Therapy in Arterial Disease. I: Available Agents (1992) (0)
Abstracts of Societies (2011) (0)
Antiarrhythmic drugs. (1983) (0)
Pharmacokinetic Properties of Cardiovascular Drugs (1985) (0)
Preparticipation cardiovascular screening: application of an extended Italian model in Scotland (2011) (0)
THE PHARMACOKINETICS OF INTRAMUSCULAR DISOPYRAMIDE PHOSPHATE (1982) (0)
199 Coagulation, fibrinolysis and viscosity during thrombolytic therapy of acute myocardial infarction with recombinant tissue plasminogen activation (rt-PA), APSAC and streptokinase (1988) (0)
202 Coagulation and fibrinolytic parameters during thrombolytic therapy of acute myocardial infarction with two-chain recombinant tissue plasminogen activator (1988) (0)
The heritability of carotid intimal medial thickness - an adult twin study (2000) (0)
Comparative efficacy of Univer and conventional verapamil in the control of ventricular response in atrial fibrillation. (1988) (0)
THEEFFECTSOF A NEW p-ADRENOCEPTOR BLOCKINGCOMPOUND, TOLAMOLOL,ON HAEMO- DYNAMICSAND MYOCARDIALFUNCTIONINMAN (1974) (0)
Transpulmonary pharmacokinetics ofanACE inhibitor (perindoprilat) inman (1991) (0)
The Haemodynamic Effects of Subcutaneous Sumatriptan: Evidence of Extracranial Vasoconstriction (1994) (0)
Atherosclerosis and Hyperlipoproteinaemia (1985) (0)
The relation of reciprocal change rc to arteriographic anatomy early in acute myocardial infarction ami (1990) (0)
Noninvasive assessment ofthehaemodynamic effects of nicardipine innormotensive subjects (1985) (0)
CLINICAL OUTCOMES AND QUALITY OF LIFE AFTER ANGIOPLASTY IN PATIENTS WITH CORONARY ARTERY DISEASE (2002) (0)
BASEM 2006 Annual Conference (2007) (0)
A dose-ranging study ofUK-68,798, anovel class III anti-arrhythmic agent, innormal volunteers (1991) (0)
Sudden death referrals to the West of Scotland Inherited Cardiac Conditions Clinic: an overview of findings in probands with a structurally normal heart (2013) (0)
044 A RANDOMISED CONTROLLED TRIAL OF DEFERRED STENTING VERSUS IMMEDIATE STENTING TO PREVENT NO-REFLOW IN ACUTE ST-ELEVATION MYOCARDIAL INFARCTION (2013) (0)
THE EFFECTS OF ACUTE DYNAMIC EXERCISE ON HAEMOSTASIS IN 1ST CLASS SOCCER REFEREES (2002) (0)
Anti-anginal efficacy of intravenous amlodipine assessed by means of atrial pacing. (1991) (0)
ARRHYTHMIAS DURING LAPAROSCOPY (1989) (0)
Sumatriptan and 5HT1 Mediated Changes in Systolic Time Intervals (1995) (0)
Scottish Society for Experimental Medicine (1987) (0)
Clinical Applications of Sodium Nitroprusside (1980) (0)
Anti Mycobacterial HSP 65 and Rheumatoid Factor Titres in a Population of Normal Twins (1994) (0)
Coronary artery patency using eminase (APSAC) in acute myocardial infarction (1987) (0)
Response to Letter Regarding Article, “Migraine Intervention With STARFlex Technology (MIST) Trial” (2009) (0)
Computerized tomography in evaluation of Cushing's syndrome. (1980) (0)
Antagonism by INPEA of isoprenaline‐induced tachycardia in man (1972) (0)
Digital subtraction angiography in adult cardiology (1986) (0)
Assessment bygeneral practitioners ofsuitability ofthrombolysis inpatients withsuspected acute myocardial infarction (1993) (0)
cardiovascular risk ? Walk or run ? Is high-intensity exercise more effective than moderate-intensity exercise at reducing (2012) (0)
QT INTERVALS IN ATHLETES (2013) (0)
Apilot study oftheefficacy andsafety ofbolus administration ofalteplase inacutemyocardial (1991) (0)
THE EFFECTS OF ISOMETRIC EXERCISE ON HAEMOSTASIS IN ISCHAEMIC HEART DISEASE. (2002) (0)
Secondary Prevention Following Acute Myocardial Infarction (1985) (0)
myocardial infarction . bolus administration of alteplase in acute A pilot study of the efficacy and safety of (0)
THE ECHOCARDIOGRAPHIC AND EXERCISE CAPACITY CHANGES SEEN PRE AND POST CLOSURE OF ATRIAL SEPTAL DEFECTS USING THE AMPLATZER SEPTAL OCCLUDER DEVICE (2002) (0)
Indications for Surgery in Coronary Heart Disease (1985) (0)

This paper list is powered by the following services:

Other Resources About Stewart Hillis

en.wikipedia.org

What Schools Are Affiliated With Stewart Hillis?

Stewart Hillis is affiliated with the following schools:

University of Glasgow